Lisdexamfetamine dimesylate, behavioral treatment combination effective for family ADHD
A combination of medication and behavioral treatments may benefit multiplex families where both children and their mothers have ADHD, according to study results published in Journal of Clinical Psychiatry...In the current study, the investigators sought to compare parental treatment with lisdexamfetamine dimesylate (LDX; Vyvanse, Shire Development) with behavioral parent training (BPT) among 35 mothers who had untreated ADHD and who had young, stimulant-naive children aged 4 to 8 years (N = 35) with ADHD symptoms.
Other Articles in this Edition
ADHD study reveals unique genetic differences in African American patients
Lisdexamfetamine dimesylate, behavioral treatment combination effective for family ADHD
The Association of Younger Age in a Classroom and Increased ADHD Medication Rates
Theresa Cerulli, MD: ADHD Students Struggling During COVID-19
Lower Writing Task Engagement Found in Children with Autism Spectrum Disorder
Kids With ADHD Benefit From Playing With Toys Instead Of Online Games
Children Are Most Likely to Be Diagnosed with ADHD by 10 Years Old